Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice
J. Clin. Invest. Siddhartha Mukherjee, et al. 118:491
doi:10.1172/JCI33102 [Go to this article.]

Problems with a PDF?